Biomarkers on melanoma patient T Cells associated with ipilimumab treatment

BACKGROUND: Ipilimumab induces long-lasting clinical responses in a minority of patients with metastatic melanoma. To better understand the mechanism(s) of action and to identify novel biomarkers associated with the clinical benefit and toxicity of ipilimumab, baseline characteristics and changes in...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Wenshi, Yu, Daohai, Sarnaik, Amod A, Yu, Bin, Hall, Maclean, Morelli, Dawn, Zhang, Yonghong, Zhao, Xiuhua, Weber, Jeffrey S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3527361/
https://www.ncbi.nlm.nih.gov/pubmed/22788688
http://dx.doi.org/10.1186/1479-5876-10-146

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3527361/
https://www.ncbi.nlm.nih.gov/pubmed/22788688
http://dx.doi.org/10.1186/1479-5876-10-146

Ejemplares similares